Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

The FDA Approach to Defining Misleading Advertising

Jacob Jacoby and Constance Small
Journal of Marketing
Vol. 39, No. 4 (Oct., 1975), pp. 65-68
DOI: 10.2307/1250601
Stable URL: http://www.jstor.org/stable/1250601
Page Count: 4
  • Read Online (Free)
  • Download ($24.00)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
The FDA Approach to Defining Misleading Advertising
Preview not available

Abstract

Misleading advertising is an important issue for the FDA. Jacoby and Small describe the approach currently being considered by the FDA for defining and empirically assessing misleading advertising.

Page Thumbnails

  • Thumbnail: Page 
65
    65
  • Thumbnail: Page 
66
    66
  • Thumbnail: Page 
67
    67
  • Thumbnail: Page 
68
    68